Evidence map›Paper›PMID 40362638›Full record

ArticleInternational journal of molecular sciences2025

CCN2 Activates Cellular Senescence Leading to Kidney Fibrosis in Folic Acid-Induced Experimental Nephropathy.

Lucia Tejedor-Santamaria, Laura Marquez-Exposito, Alicia Villacampa, Vanessa Marchant, Antonio Battaglia-Vieni, Sandra Rayego-Mateos, Raul R Rodrigues-Diez, Fatima Milhano Santos, Floris A Valentijn, Sebastian N Knoppert and 8 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lucia Tejedor-SantamariaMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.ORCID 0000-0003-4295-7284
Laura Marquez-ExpositoMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.
Alicia VillacampaDepartment of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Vanessa MarchantMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.ORCID 0000-0002-2767-0229
Antonio Battaglia-VieniMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.ORCID 0009-0005-3402-1859
Sandra Rayego-MateosMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.
Raul R Rodrigues-DiezDepartment of Cell Biology, School of Medicine, Complutense University, 28040 Madrid, Spain.
Fatima Milhano SantosMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.ORCID 0000-0002-4041-1504
Floris A ValentijnDepartment of Pathology, University Medical Center Utrecht, H04.312, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0003-3676-6596
Sebastian N KnoppertDepartment of Pathology, University Medical Center Utrecht, H04.312, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Roel BroekhuizenDepartment of Pathology, University Medical Center Utrecht, H04.312, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-5495-9327
María Piedad Ruiz-TorresDepartment of Systems Biology, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Roel GoldschmedingDepartment of Pathology, University Medical Center Utrecht, H04.312, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Alberto OrtizInstituto de Salud Carlos III., 28029 Madrid, Spain.ORCID 0000-0002-9805-9523
Concepción PeiróDepartment of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.ORCID 0000-0002-9690-7816
Tri Q NguyenDepartment of Pathology, University Medical Center Utrecht, H04.312, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0001-6475-0706
Adrián M RamosInstituto de Salud Carlos III., 28029 Madrid, Spain.
Marta Ruiz-OrtegaMolecular and Cellular Biology in Renal and Vascular Pathology, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.ORCID 0000-0002-1495-6535

Funding

INNOREN P2022/BMD-7221Instituto de Salud Carlos III (ISCIII) CD23/00049Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union PI23/00394, PI21/01453Plan Nacional I+D PID2023-147378OB-I00RICORS2040 RD21/0005/0002Salud Carlos III (ISCIII) CP23/00025
6 · The paper itself

Abstract

Cellular communication network factor 2 (CCN2, also known as CTGF) is a complex protein that regulates numerous cellular functions. This biomolecule exhibits dual functions, depending on the context, and can act as a matricellular protein or as a growth factor. CCN2 is an established marker of fibrosis and a well-known mediator of kidney damage, involved in the regulation of inflammation, extracellular matrix remodeling, cell death, and activation of tubular epithelial cell (TECs) senescence. In response to kidney damage, cellular senescence mechanisms are activated, linked to regeneration failure and progression to fibrosis. Our preclinical studies using a total conditional CCN2 knockout mouse demonstrate that CCN2 plays a significant role in the development of a senescence phenotype after exposure to a nephrotoxic agent. CCN2 induces cell growth arrest in TECs, both in the early phase and in the chronic phase of folic acid nephropathy (FAN), associated with cell-death/necroinflammation and fibrosis, respectively. Renal CCN2 overexpression was found to be linked to excessive collagen accumulation in tubulointerstitial areas, microvascular rarefaction, and a decline in renal function, which were observed three weeks following the initial injury. All these findings were markedly diminished in conditional CCN2 knockout mice. In the FAN model, injured senescent TECs are associated with microvascular rarefaction, and both were modulated by CCN2. In primary cultured endothelial cells, as previously described in TECs, CCN2 directly induced senescence. The findings collectively demonstrate the complexity of CCN2, highlight the pivotal role of cellular senescence as an important mechanism in renal injury, and underscore the critical function of this biomolecule in kidney damage progression.

Indexed as

Cellular SenescenceConnective Tissue Growth FactorFolic AcidKidneyKidney DiseasesAnimalsDisease Models, AnimalEpithelial CellsFibrosisKidney TubulesMaleMiceMice, KnockoutCCN2 protein, mouseConnective Tissue Growth FactorFolic AcidAKICCN2CKDfibrosismicrovascular rarefactionsenescence

Identifiers

PMID40362638
PMCPMC12072722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.